Yi-chun J. Liu
No.135, Nanhsiao Street, 500
Chang-hua, TNQ, Taiwan
Chang-hua, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Diagnostic probability change across follow-up: a Bayesian EHR cohort study in psychiatry.
Journal: Diagnosis (Berlin, Germany)
Published: February 10, 2026
Dose-response, net clinical benefit and optimal dose ranges of stimulants in children and adolescents with ADHD: a network meta-analysis.
Journal: European child & adolescent psychiatry
Published: January 26, 2026
Clinical Plausibility in Large Language Model Robustness Testing for Medicine: A Scoping Review.
Journal: Journal of medical systems
Published: October 18, 2025
Corrigendum to "Massive nasal bleeding in nasopharyngeal carcinoma: incidence, risk predictors, and survival impact" [Oral Oncol. 167 (2025) 107456].
Journal: Oral oncology
Published: July 05, 2025
Collective motion of methylammonium cations affects phase transitions and self-trapped exciton emission in A-site engineered MAPbI3 films.
Journal: Nanoscale advances
Published: June 17, 2025
A retrospective analysis of the effects of COVID-19 on cancer diagnosis and staging in Taiwan.
Journal: Journal of infection in developing countries
Published: May 27, 2025
Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact: Running title: Massive nasal bleeding in NPC.
Journal: Oral oncology
Published: April 24, 2025
Mapping psychiatric comorbidity network: A pilot multi-method weighted network analysis with a focus on key disorders.
Journal: Comprehensive psychiatry
Published: February 23, 2025
Assessing bias in AI-driven psychiatric recommendations: A comparative cross-sectional study of chatbot-classified and CANMAT 2023 guideline for adjunctive therapy in difficult-to-treat depression.
Journal: Psychiatry research
Published: January 22, 2025
Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy.
Journal: Cell reports. Medicine
Published: January 12, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2025
Last Updated: 09/26/2026